What is PatSnap?

Imperial College professor outlines key considerations when outsourcing IP management

I had the pleasure of interviewing Ian Harvey, Chairman of the IP Centre Advisory Board of Tsinghua University x-lab and adjunct professor in intellectual property (IP) at Imperial College Business School. Ian has a wealth of experience in IP and and was the former CEO of BTG, where IP management was at the core of their business. IP matters were handled in-house however, in this interview, he tells us what to consider when outsourcing IP.

Read More

PatSnap Insights: Pfizer's Viagra Patent Expires

Viagra, or Sildenafil Citrate, is currently patented by Pfizer in the United States, and the patent is set to expire there in April 2020. The company has already signed an agreement to allow Teva Pharmaceuticals to bring a generic Viagra drug to the US market by the end of 2017, and for such an important drug, the implications for both Pfizer and the wider market are expected to be significant. The original patent can be found here in the PatSnap database: US6469012.

Read More

How does IP data from patents supercharge R&D?

 

Read More

The Profitable and Low-Risk Approach to Patent Portfolio Pruning

The very idea of a patent portfolio that needs pruning is offensive to some—isn’t it wasteful to grow something so large that you need to regularly shear huge chunks off it? Not necessarily. 

Read More

PatSnap Platform Upgrade: Japanese Interface, Custom Fields & Patent Value Metrics

The August edition of our series on major upgrades to our platform covers features that further personalise your experience of using PatSnap: 

Read More

What makes the best TTO and industry collaborators so successful at innovation?

Arundeep Pradhan, former president of the Association of University Technology Managers (AUTM), published on 14 August 2017 an article titled, “Licensing efficiency of academic technology transfer: are there better indicators?”

Read More

How to apply Blue Ocean Strategy to IP

Read More

What are the major barriers to R&D and IP collaboration and how can they be avoided?

For any new product development project, it’s important for the R&D team and IP team to work together. However, the reality is that collaboration between the two departments can be very difficult as they come from different worlds. R&D are often risk takers but IP teams are usually more risk averse. What I wanted to find out is what the major barriers to R&D and IP team collaboration are - and how they can be avoided.

Read More

IP Expert’s Cheat Sheet on Non-Disclosure Agreements (NDAs) That Won’t Give You Headaches

Jurgen Vollrath is the expert you want on your side when it comes to all things intellectual property. He was chief intellectual property (IP) officer at SAP and is president of Exponential Technology Counsel

Read More

Top 3 Tech M&As of 2017: Identifying Threats & Opportunities Using IP Data

Every M&A deal happens because a company wants something and it thinks that acquiring another company (or type of company) will lead to the desired outcome. This article will explain how the acquiring company can use intellectual property (IP) data to:

Read More